Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0S9MU
|
||||
Former ID |
DAP000220
|
||||
Drug Name |
Rizatriptan
|
||||
Synonyms |
Risatriptan; Rizatriptanum; Rizatriptan benzoat; MK 462 free base; Maxalt (TN); Rizaliv (TN); Rizalt (TN); Rizatriptan (INN); Rizatriptan [INN:BAN]; N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine; N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine; N,N-Dimethyl-2-[5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylamine; N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine; N,N-dimethyl-2-[5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Antiinflammatory Agents
|
||||
Company |
Merck & Co
|
||||
Structure |
Download2D MOL |
||||
Formula |
C15H19N5
|
||||
InChI |
InChI=1S/C15H19N5/c1-19(2)6-5-13-8-17-15-4-3-12(7-14(13)15)9-20-11-16-10-18-20/h3-4,7-8,10-11,17H,5-6,9H2,1-2H3
|
||||
InChIKey |
ULFRLSNUDGIQQP-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 145202-66-0
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
7380056, 7980527, 8153125, 15221855, 26612819, 26749916, 29224147, 46506557, 46530620, 48416524, 49830967, 49984083, 50173225, 57322597, 85209524, 92718843, 93166519, 96025171, 99373553, 103236413, 103941727, 104308214, 125001917, 125728524, 126621280, 126658125, 126667003, 129384422, 131299041, 134337535, 134358454, 135110600, 135650905, 135684127, 136375513, 137002445, 139157639, 143494842, 144205087, 152036015, 152239970, 160964292, 162011662, 172091432, 174007052, 174477513, 174527522, 175266240, 176484738, 179116883
|
||||
ChEBI ID |
ChEBI:48273
|
||||
SuperDrug ATC ID |
N02CC04
|
||||
SuperDrug CAS ID |
cas=144034800
|
||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 1D receptor | Target Info | Agonist | [535607] | |
References | |||||
Ref 468161 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 51). | ||||
Ref 538326 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 077263. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.